| Christopher Brian Cross, MD | |
|
6801 Rogers Ave, Fort Smith, AR 72903-4067 | |
| (479) 274-3200 | |
| (479) 274-3289 |
| Full Name | Christopher Brian Cross |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 17 Years |
| Location | 6801 Rogers Ave, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013170596 | NPI | - | NPPES |
| 200533550A | Other | OK | OKLAHOMA MEDICAID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | E8507 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Fort Smith Communities | 3870668510 | 273 |
News Archive
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
Federal officials have said that Medicare's controversial new drug benefit for seniors, may in fact cost less than first projected, because of the very competitive bids from insurers and other providers.
Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.
Idera Pharmaceuticals, Inc. announced today the presentation of data from a Phase 1 clinical trial evaluating IMO-2125, a novel immune modulator, in null-responder patients with chronic hepatitis C virus (HCV) infection.
We often think of tripping over a step edge or pathway obstruction but there can be a range of things that can contribute to a fall. One of the most common is that our ability to balance can be reduced. This means that we don't recover from a trip and are at more of a risk of losing our balance.
› Verified 9 days ago
| Entity Name | Cooper Clinic Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154341931 PECOS PAC ID: 1153219621 Enrollment ID: O20040607000412 |
News Archive
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
Federal officials have said that Medicare's controversial new drug benefit for seniors, may in fact cost less than first projected, because of the very competitive bids from insurers and other providers.
Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.
Idera Pharmaceuticals, Inc. announced today the presentation of data from a Phase 1 clinical trial evaluating IMO-2125, a novel immune modulator, in null-responder patients with chronic hepatitis C virus (HCV) infection.
We often think of tripping over a step edge or pathway obstruction but there can be a range of things that can contribute to a fall. One of the most common is that our ability to balance can be reduced. This means that we don't recover from a trip and are at more of a risk of losing our balance.
› Verified 9 days ago
| Entity Name | Mercy Clinic Fort Smith Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902073620 PECOS PAC ID: 3870668510 Enrollment ID: O20080814000789 |
News Archive
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
Federal officials have said that Medicare's controversial new drug benefit for seniors, may in fact cost less than first projected, because of the very competitive bids from insurers and other providers.
Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.
Idera Pharmaceuticals, Inc. announced today the presentation of data from a Phase 1 clinical trial evaluating IMO-2125, a novel immune modulator, in null-responder patients with chronic hepatitis C virus (HCV) infection.
We often think of tripping over a step edge or pathway obstruction but there can be a range of things that can contribute to a fall. One of the most common is that our ability to balance can be reduced. This means that we don't recover from a trip and are at more of a risk of losing our balance.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Brian Cross, MD 6801 Rogers Ave, Fort Smith, AR 72903-4067 Ph: (479) 274-2000 | Christopher Brian Cross, MD 6801 Rogers Ave, Fort Smith, AR 72903-4067 Ph: (479) 274-3200 |
News Archive
Judith Villablanca, MD, of The Saban Research Institute of Children's Hospital Los Angeles, Susan Kreissman, MD, of Duke University Medical Center, and colleagues reported the results of a randomized, phase 3 clinical trial conducted by the Children's Oncology Group examining the effect of selectively removing (purging) tumor cells from blood stem cells before they are transplanted back into patients with high-risk neuroblastoma following high-dose chemotherapy.
Federal officials have said that Medicare's controversial new drug benefit for seniors, may in fact cost less than first projected, because of the very competitive bids from insurers and other providers.
Researchers at the UNC School of Medicine have devised a new biochemical technique that will allow them and other scientists to delve much deeper than ever before into the specific cellular circuitry that keeps us healthy or causes disease.
Idera Pharmaceuticals, Inc. announced today the presentation of data from a Phase 1 clinical trial evaluating IMO-2125, a novel immune modulator, in null-responder patients with chronic hepatitis C virus (HCV) infection.
We often think of tripping over a step edge or pathway obstruction but there can be a range of things that can contribute to a fall. One of the most common is that our ability to balance can be reduced. This means that we don't recover from a trip and are at more of a risk of losing our balance.
› Verified 9 days ago
Dr. David A Hebert, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 7301 Rogers Ave, Fort Smith, AR 72903 Phone: 479-314-6000 | |
Fiorella Nawar, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1001 Towson Ave, Fort Smith, AR 72901 Phone: 479-709-7402 | |
Charles Moussallem, M.D Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1500 Dodson Ave, Suite 280, Fort Smith, AR 72901 Phone: 479-709-7480 Fax: 479-709-7479 | |
Dr. Jason Glenn Daily, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-4000 Fax: 479-274-4099 | |
Ongkarn Sarasombath, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-2000 Fax: 479-274-2194 | |
Dr. Jacob K Joseph, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6801 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-3200 Fax: 479-274-3289 |